From Wikipedia, the free encyclopedia
A nicotinic antagonist is a type of anticholinergic which inhibits the action at nicotinic acetylcholine receptors. These compounds are mainly used for peripheral muscle paralysis in surgery, but some centrally acting compounds such as bupropion, mecamylamine and 18-methoxycoronaridine block nicotinic acetylcholine receptors in the brain and can be used for treating drug addiction.
[edit] References
[edit] External links
Skeletal Muscle relaxants (M03) |
|
Peripherally acting
(primarily antinicotinic,
neuromuscular-blocking drugs) |
Curare Alkaloids
(Non-Depolarising)
|
|
|
|
Atracurium, Cisatracurium, Doxacurium chloride, Fazadinium bromide, Gallamine, Hexafluronium, Metocurine, Mivacurium chloride, Pancuronium, Pipecuronium bromide, Rocuronium bromide, Vecuronium
|
|
|
|
|
Other
|
|
|
|
Centrally Acting |
|
|
|
|
|
|
|
|
|
Other
|
Baclofen, Chlormezanone, Chlorzoxazone, Donepezil, Mephenesin, Mephenoxalone, Phenyramidol, Pridinol, Quinine, Thiocolchicoside, Tizanidine, Tolperisone
|
|
|
Directly acting |
|
|